NCT07120308View on ClinicalTrials.gov

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

January 30, 2023

Study Completion Date

January 30, 2023

Conditions

Corneal Epithelial Defect

Interventions

DRUG

ZKY001 eye drops

Administer to eyes

DRUG

Vehicle (placebo)

Administer to eyes

Trial Locations (1)

Unknown

Xiamen Eye Center of Xiamen University, Xiamen

All Listed Sponsors

lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY

NCT07120308 - To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis | Biotech Hunter | Biotech Hunter